Notizie

6 10, 2013

La Diatech partecipa al “Fifth International Symposium: Primary systemic treatment in the management of operable Breast Cancer”
La Diatech partecipa al “Fifth International Symposium: Primary systemic treatment in the management of operable Breast Cancer”

Notizie

La Diatech partecipa al “Fifth International Symposium: Primary systemic treatment in the management of operable Breast Cancer”

Diatech Pharmacogenetics2022-04-20T12:55:43+02:00

3 10, 2013

Dieci sistemi operativi Myriapod in Italia

Diatech Pharmacogenetics2022-04-20T12:55:43+02:00

30 09, 2013

Diatech Pharmacogenetics sponsor della Settimana del Buon Vivere

Diatech Pharmacogenetics2022-04-20T12:55:43+02:00

29 08, 2013

Diatech Pharmacogenetics aggiorna i propri kit per analisi di KRAS e NRAS sulla base della nota informativa Amgen-Aifa del 14/08/2013.

Diatech Pharmacogenetics2017-08-23T12:54:14+02:00

28 03, 2013

Siglato accordo tra Diatech Pharmacogenetics e Horizon Discovery UK

Diatech Pharmacogenetics2017-08-23T14:53:35+02:00

12 11, 2012

Diatech Pharmacogenetics al XVIII Congreso Italiano della Fibrosi Cistica

Diatech Pharmacogenetics2017-08-23T14:57:43+02:00

26 10, 2012

Fare impresa in una Fabriano che Cambia

Diatech Pharmacogenetics2017-08-23T15:05:40+02:00

26 09, 2012

Il cancro in Italia, presentato dal Ministero della Salute

Diatech Pharmacogenetics2017-08-23T15:10:26+02:00

24 07, 2012

Fluorescent Long DNA Test (IRST Meldola e Diatech ) inizia con la validazione

Diatech Pharmacogenetics2017-08-23T15:20:00+02:00

21 05, 2012

MGMT e terapia personalizzata del glioblastoma

Diatech Pharmacogenetics2017-08-23T15:48:46+02:00

Precedente 171819 Successivo